Adare Pharmaceuticals:Product out-licensing opportunities to enhance your portfolio

June 16, 2015

 Is your company trying to expand its expertise into other therapeutic categories? Are you looking to grow your product portfolio? Adare has a diverse portfolio of products available for out-licensing. 


 

Is your company trying to expand its expertise into other therapeutic categories? Are you looking to grow your product portfolio? Adare has a diverse portfolio of products available for out-licensing.

 

Using our proprietary drug delivery technologies, we’ve created new formulations of Rx and OTC products with proven patient benefits. We out-license these products to pharmaceutical companies for commercialization around the world.

 

Here are just a few of our products that are available for out-licensing in select territories:

  • Cyclobenzaprine ER 15 mg, 30 mg Extended Release Capsules 
  • A once-daily formulation of muscle relaxant that provides a very low rate of somnolence/daytime drowsiness

  • Incorporates Diffucaps® Customized Release Technology

  • Diphenhydramine ODT 25 mg Orally Disintegrating Tablets
  • An oral anti-histamine that also treats insomnia-formulated as a convenient, easy-to-swallow ODT

  • Incorporates Microcaps® Taste Masking Technology and AdvaTab® Orally Disintegrating Tablets

  • InnoPran XL® (propranolol HCl) 80 mg, 120 mg Extended Release Capsules
  • A beta-adrenergic blocker indicated for the treatment of hypertension to lower blood pressure

  • Incorporates Diffucaps® Customized Release Technology

 

To learn more about additional product out-licensing opportunities, contact Lisa.Miller@adarepharma.com or visit www.AdarePharma.com.

 

©2015 Adare Pharmaceuticals, Inc.